6938 — Suzhou Ribo Life Science Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMid CapSucker Stock

Annual balance sheet for Suzhou Ribo Life Science Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—
Source:	PROSPECTUS	PROSPECTUS	PRESS
Standards:	IFRS	IFRS	—
Status:	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	210	168	407
Net Total Accounts Receivable
Net Total Receivables	40.7	35.5	5.46
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	309	269	517
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	297	276	245
Net Intangible Assets
Long Term Notes Receivable
Other Long Term Assets
Total Assets	716	651	840
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	328	414	601
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Minority Interest
Total Other Liabilities
Total Liabilities	611	761	934
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	105	-110	-93.9
Total Liabilities & Shareholders' Equity	716	651	840
Total Common Shares Outstanding